Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro

Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro

Background: Metabolic associated fatty liver disease (MAFLD), characterized by hepatic lipid accumulation and fatty degeneration, is intertwined with obesity and type 2 diabetes mellitus (T2DM). Empagliflozin is a sodium-glucose cotransporter-2 inhibitor that effectively lowers blood glucose, but it...

Full description

Bibliographic Details
Main Authors:	Ting Li, Ting Fang, Linxin Xu, Xiangyang Liu, Xiaoyu Li, Mei Xue, Xiaochen Yu, Bei Sun, Liming Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Pharmacology
Subjects:	empagliflozin autophagy diabetes metabolic associated fatty liver disease lipid accumulation ten-eleven translocation 2
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.622153/full

Similar Items

Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro
by: Ting Li, et al.
Published: (2025-01-01)

Tet2-mediated responses to environmental stress
by: Woo Seok Song, et al.
Published: (2023-12-01)

THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA
by: Enas A Dammag, et al.
Published: (2020-01-01)

Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinoma
by: Tao Cheng, et al.
Published: (2024-03-01)

Role of DNA dioxygenase Ten-Eleven translocation 3 (TET3) in rheumatoid arthritis progression
by: Akio Kawabe, et al.
Published: (2022-09-01)

5hmC modification regulates R-loop accumulation in response to stress
by: Xingyun Xu, et al.
Published: (2023-06-01)

MiR-326 sponges TET2 triggering imbalance of Th17/Treg differentiation to exacerbate pyroptosis of hepatocytes in concanavalin A-induced autoimmune hepatitis
by: Genglin Zhang, et al.
Published: (2024-03-01)

Aerobic exercise alters DNA hydroxymethylation levels in an experimental rodent model of temporal lobe epilepsy
by: Silvienne C. Sint Jago, et al.
Published: (2024-01-01)

Ten-Eleven Translocation 1 and 2 Enzymes Affect Human Skin Fibroblasts in an Age-Related Manner
by: Paulina Kołodziej-Wojnar, et al.
Published: (2023-06-01)

DNA methylation modification in Idiopathic pulmonary fibrosis
by: Lu Ren, et al.
Published: (2024-06-01)

ROS attenuates TET2-dependent ZO-1 epigenetic expression in cerebral vascular endothelial cells
by: Lan Wang, et al.
Published: (2022-09-01)

5‐Hydroxymethylcytosine: a new kid on the epigenetic block?
by: Filomena Matarese, et al.
Published: (2011-12-01)

Decoding the role of DNA methylation in allergic diseases: from pathogenesis to therapy
by: Ruiming Han, et al.
Published: (2024-07-01)

mRNA Expressions of Methylation Related Enzymes and Duration of Thermal Conditioning in Chicks
by: Yoshimitsu Ouchi, et al.
Published: (2022-01-01)

Identification and interpretation of TET2 noncanonical splicing site intronic variants in myeloid neoplasm patients
by: Riku Das, et al.
Published: (2023-08-01)

Ten-eleven translocation 1 mediating DNA demethylation regulates the proliferation of chicken primordial germ cells through the activation of Wnt4/β-catenin signaling pathway
by: Yinglin Lu, et al.
Published: (2024-03-01)

Case report: Successful use of ruxolitinib to treat interstitial pneumonia as an unusual primary presentation in primary myelofibrosis—two birds with one stone
by: Pingping Xiao, et al.
Published: (2024-11-01)

Overexpression of DNA demethylase ten-eleven translocation 3 mediates high expression of Krüppel-like factor 4 in the skin lesions of patients with psoriasis vulgaris
by: ZHANG Shuai, et al.
Published: (2024-03-01)

Exercise Ameliorates Spinal Cord Injury by Changing DNA Methylation
by: Ganchimeg Davaa, et al.
Published: (2021-01-01)

Melatonin: A Potential Regulator of DNA Methylation
by: Kinga Linowiecka, et al.
Published: (2023-05-01)

TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway
by: Zhu Maoling, et al.
Published: (2022-12-01)

Punicalagin prevents obesity-related cardiac dysfunction through promoting DNA demethylation in mice
by: Shengjie Pei, et al.
Published: (2024-05-01)

Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor
by: Lin-Yu Chen, et al.
Published: (2024-06-01)

Loss of TET2 increases B-1 cell number and IgM production while limiting CDR3 diversity
by: Emily Dennis, et al.
Published: (2024-03-01)

Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer
by: Garett J. Steers, et al.
Published: (2023-08-01)

The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistance
by: Hafiza Bushra Manzoor, et al.
Published: (2024-01-01)

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy
by: Zhang Z, et al.
Published: (2021-01-01)

Effect of DNA methylation on the osteogenic differentiation of mesenchymal stem cells: concise review
by: Zhihao Lai, et al.
Published: (2024-07-01)

TDG is a novel tumor suppressor of liver malignancies
by: Haider M. Hassan, et al.
Published: (2020-07-01)

Empagliflozin Alleviates Carfilzomib-Induced Cardiotoxicity in Mice by Modulating Oxidative Stress, Inflammatory Response, Endoplasmic Reticulum Stress, and Autophagy
by: Mina Y. George, et al.
Published: (2024-05-01)

Empagliflozin mitigates methotrexate-induced nephrotoxicity in male albino rats: insights on the crosstalk of AMPK/Nrf2 signaling pathway
by: Amal Anwar Mishriki, et al.
Published: (2024-07-01)

Mechanism of the cardioprotective effect of empagliflozin on diabetic nephropathy mice based on the basis of proteomics
by: Zongchao Yu, et al.
Published: (2024-10-01)

Regulation and Functional Significance of 5-Hydroxymethylcytosine in Cancer
by: Vittal Rangan Arvinden, et al.
Published: (2017-11-01)

The Ameliorative Effect of Empagliflozin in Vigabatrin-Induced Cerebellar/Neurobehavioral Deficits: Targeting mTOR/AMPK/SIRT-1 Signaling Pathways
by: Rabab M. Amer, et al.
Published: (2022-06-01)

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
by: Xiaoyi Chen, et al.
Published: (2023-03-01)

Green quantitative methods for linagliptin and empagliflozin in dosage forms
by: Fraihat Safwan M.
Published: (2024-04-01)

A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects
by: Xu Jiang, et al.
Published: (2024-04-01)

Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells
by: Junping Li, et al.
Published: (2023-11-01)

Empagliflozin-Enhanced Antioxidant Defense Attenuates Lipotoxicity and Protects Hepatocytes by Promoting FoxO3a- and Nrf2-Mediated Nuclear Translocation via the CAMKK2/AMPK Pathway
by: Yangyang Wang, et al.
Published: (2022-04-01)

Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation
by: Youhong Luo, et al.
Published: (2024-09-01)